866-945-0263 | enquiries@arrowheadpublishers.com

August 11, 2016

Arrowhead Publishers Releases New Report Covering Growing Field of Microbiome Therapeutics and Diagnostics

The human microbiome is an exciting revolutionary field captivating growing interest of biotech startup’s, Big Pharma and academia. Since the Human Microbiome Project (HMP) and a surge in Next Generation Sequencing (NGS) and meta-omic tools; increasing efforts are underway to investigate the role of the human microbiome in health and disease and create innovative biotherapeutic and diagnostic products. 

August 4, 2016

Vivozon to Present Practical Methodology in Identifying Antionociceptive Multi-Target Drugs at Upcoming 10th Annual Pain Therapeutics Summit
 
As the steady decline of newly developed single-targeted drugs is becoming a challenge in the field, researchers are preferring to use a practical methodology in identifying antionociceptive multi-target drugs. The design of this approach allows for drugs to reflect multifactorial diseases caused by intricate networks of various mechanisms. A recent review on the revolutionary trend in pursuing multi-targeting drugs has been released by several researchers in the field of neuropathic pain. 
 

August 4, 2016

Quest Diagnostics to Present Challenges of Commercializing Companion Diagnostics at 8th Annual Personalized & Precision Medicine Conference

Quest Diagnostics and Inovalon received two gold medals at the 2016 Golden Bridge Awards for Data Diagnostics™, a point-of-care health analytics technology. Data Diagnostics is a suite of individualized analytical reports that physicians can use to enhance patient recommendations. Quest’s 20 billion clinical laboratory test results, combined with Inovalon’s big data analytics platform, allows for data to be analyzed in real time from more than 132 million patients.

August 2, 2016

Centrexion Therapeutics to Present on Collaborative Pain Research with BioXcel at 10th Annual Pain & Migraine Therapeutics Summit
 
Centrexion Therapeutics has announced a collaborative agreement with BioXcel to develop and commercialize innovative chronic pain therapeutics.
 

August 1, 2016

Research on an fMRI-Based Neurologic Signature of Physical Pain to be Presented at Upcoming 10th Annual Pain & Migraine Therapeutics Summit

As persistent pain is solely measured by self-report, research is currently being conducted to find objective methods of identifying physical pain in the brain. Researcher teams from various universities have discovered an imaging-based signature to predict pain sensitivity using functional magnetic resonance imaging (fMRI) and machine learning. 

Contact Us

5780 Lincoln Drive, Suite 205
Edina, MN 55436 USA
866-945-0263
www.arrowheadpublishers.com
enquiries@arrowheadpublishers.com

Speaker Opportunities

If you are interested in speaking at one of Arrowhead's conferences or would like to suggest a conference theme for which you have particular expertise, we'd like to hear from you.

Sponsor/Exhibitor Opportunities

Arrowhead sponsorship and exhibitor levels are designed to give your organization the highest level of exposure and opportunity to market products and branding in an environment that is targeted toward facilitating professional networking. We can also build tailor-made packages that will meet your organization's marketing budget and goals. Arrowhead sponsorships are proven to help grow businesses through direct and targeted exposure to industry leaders and decision makers. To gain critical industry exposure via our sponsorship and exhibiting opportunities, please contact us.